RSS

Type 1 diabetes

The European Medicines Agency (EMA) has accepted Sanofi’s regulatory submission for sotagliflozin, a potential treatment for type 1 diabetes, for review. more

News

A device that takes inspiration from a spider’s web that may be a game-changer in the control of Type 1 diabetes has been developed by researchers from Cornell University. more

Technology

A potential new therapy for type I diabetes patients has been found to be safe and does not accelerate decline in β cell function — important in the production of insulin — in a recently published clinical trial. more

News

According to a recent clinical trial performed by Nemaura Pharma on type 1 diabetic patients, its Memspatch Insulin Micro-needle Device (IMD) may offer relief to patients with a fear of needles and injections. more

News

Patients have been found illegally selling prescription drugs through the online auction website, eBay. more

News

New collaboration between Sanofi and Verily Life Sciences aims to help people with diabetes live full, healthy lives. more

News

Sanofi and the life sciences team at Google are teaming up to improve care and outcomes for people with type 1 and type 2 diabetes more

News

The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. more

News